Eli Lilly and Company

Postdoctoral Research Scientist - Health Economics and Outcomes

Chester, Maryland, United States

Auto‑apply with AI Apply

Not SpecifiedCompensation

InternshipExperience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Candidates must hold a doctoral degree in an appropriate discipline such as economics, epidemiology, health services, pharmacoeconomics, psychology, statistics, or another relevant science. Experience in health economic and outcomes research (HEOR), health services research (HSR), or real-world evidence (RWE) is preferred. Strong analytical skills, including expertise in statistical analysis, economic modeling, clinical trials, observational/epidemiologic research, and health technology assessment, are required. Familiarity with common statistical software and an understanding of clinical, economic, and patient-reported outcomes methodologies are also necessary.

Responsibilities

The Postdoctoral Research Scientist will develop health outcomes research for patients, population-based decision-makers, and providers, focusing on disease states and health services of interest to Lilly. They will execute health outcomes studies, conduct analytics, and utilize analytical tools. The role involves communicating study findings to internal audiences and disseminating them to the scientific community, collaborating with medical affairs and commercial teams, and supporting the Lilly portfolio of medications by increasing or developing knowledge and use of real-world evidence, patient-focused outcomes, economic modeling, and health technology assessment submissions. The candidate will also contribute to the development of various types of research studies for publication and increase understanding of healthcare systems in the US and clinical trial research.

Skills

Health Economics

Outcomes Research

Health Services Research

Real-World Evidence

Statistical Analysis

Economic Modeling

Clinical Trials

Epidemiologic Research

Health Technology Assessment

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Key Metrics

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free